Navigation Links
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results
Date:7/29/2010

enter at the University of Texas Health Science Center in San Antonio; - Poster presentations at the ASCO 2010 Annual Meeting covering the structures of a "Phase II study of reovirus with paclitaxel (P) and carboplatin (C) in patients with metastatic non-small cell lung cancer (NSCLC) who have Kras or EGFR-activated tumors" and a "Phase I/II trial of reovirus serotype 3-Dearing strain in patients with recurrent ovarian cancer"; - The decision to initiate a U.S. Phase I study of REOLYSIN in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022); - Completion of Phase I patient enrollment in a Phase I/II clinical trial to investigate the use of REOLYSIN for patients with recurrent malignant gliomas (REO 007);

Preclinical Program

        -  A paper entitled "Antiangiogenic cancer therapy combined with
           oncolytic virotherapy leads to regression of established tumors in
           mice," co-senior authored by Dr. Richard Vile of the Department of
           Immunology, Mayo Clinic, Rochester, Minnesota, USA, and Dr. Kevin
           Harrington of the Institute of Cancer Research, London, UK, was
           published in the online version of the Journal of Clinical
           Investigation;
        -  A poster presentation at the AACR Annual Meeting entitled
           "Molecular pathways associated with REOLYSIN and gemcitabine
           synergy in ras-mutated human HCT116 cells," covering work done to
           better understand the mechanisms associated with the cytotoxic
           synergies in this combined approach in colorectal cancer cell
           lines;
        -  A poster presentation at the AACR Annual Meeting entitled "The
          
'/>"/>
SOURCE  Oncolytics Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent
2. Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting
3. Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
4. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
5. Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
6. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting
7. Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study
8. Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
9. Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results
10. Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
11. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Insero Health, Inc., a company developing natural compounds to ... disorders, is today reporting top-line results from a Phase ... with drug-resistant epilepsy.  The data are being presented at ... by Dr. Steven Schachter , Harvard ... Board.  In this study, INS001 appeared safe and well ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ has ... predict the adverse and therapeutic effects of a drug. ... Biology at the Genomics Laboratory, Covance, will discuss the ... when used as part of the QC process. Additionally, ... to identify key clinical targets even in complex data ...
(Date:5/17/2013)... Rust removal is one of home maintenance's essential ... be damaged. To help rust contractors make it less expensive, ... rust remover it called Rusterizer. It announced that for ... , My Cleaning Products explained that rust could damage items ... them. The first one, it said, happens when rust ...
(Date:5/17/2013)... 17, 2013 Tooth decay is an epidemic ... signs of the disease. The World Health Organization says that ... of adults have cavities. What are the long-term effects of ... a strong connection between the oral bacterial imbalance and serious ... so rampant, yet it is also 100% preventable? Answer: there ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... , PHOENIX and SAN CARLOS, Calif., Oct. 10 ... data today from its Phase 2 clinical trial of ... (AAPM) 20th Annual Clinical Meeting in Phoenix, Arizona. ... stage investigational product candidate in clinical development for the ...
... developing new sensors to detect chemical agents and illegal drugs ... terrorist attacks. The devices will use special gel pads ... sample which is then analysed by a scanning instrument that ... allow better, faster decisions to be made in response to ...
... N.C. The natural cycle of building bone to maintain ... calcium needs is delicately balanced, but diseases like osteoporosis break ... bone fractures. The results from a new study ... be able to fight osteoporosis and other degenerative bone diseases. ...
Cached Biology Technology:Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix 2Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix 3Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix 4New technology detects chemical weapons in seconds 2New approach for growing bone comes from Duke preclinical research 2
(Date:5/16/2013)... of us don,t ponder our pulses outside of the gym. ... to monitor heart health. , Zhenan Bao, a professor of ... than a dollar bill and no wider than a postage ... on the wrist, is sensitive enough to help doctors detect ... day be used to continuously track heart health and provide ...
(Date:5/16/2013)... Germany , May 16, 2013 ... Value Enhancement Award on Tuesday to Germany,s ... its exceptional biometric border control system. DERMALOG ... with the Best Practices Award in the category Global ... its cutting edge Biometric   Border Control System ...
(Date:5/15/2013)... "keystone" molecules that have powerful behavioral effects on ... in structuring ecosystems, according to a theory proposed ... The authors of the theory, Ryan P. Ferrer ... of the University of California at Los Angeles, ... plants that may be uncommon but exert a ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... Genomics Browser developed by researchers at the University of ... and analyze data from studies aimed at improving cancer ... disease. The browser consists of a suite ... in the huge amounts of clinical and genomic data ...
... toads are far more susceptible to being killed and eaten ... in the British Ecological Society,s journal Functional Ecology ... could help control the spread of this alien invasive species ... Georgia Ward-Fear, Matt Greenlees and Greg Brown from the University ...
... organisms with no nervous system or brain. So how ... complex community called a biofilm "decide" between different physiological ... forms the biofilm)? In the prestigious 2009 ... meeting in Harrogate, (Monday 30 March) Dr Nicola Stanley-Wall ...
Cached Biology News:Cancer Genomics Browser gives cancer researchers a powerful new tool 2Cancer Genomics Browser gives cancer researchers a powerful new tool 3Cancer Genomics Browser gives cancer researchers a powerful new tool 4Aussie meat ants may be invasive cane toad's Achilles' heel 2
... 5 gasket slides/kit Gasket slide kit (1x ... or Gasket slide ... of disposable gasket slides offered in either 11K or ... formats. The gaskets are carefully fabricated and batch ...
... General description: self locking design ... is a new product number, created ... If showing no availability yet, please ... (Z71,348-1) or contact customer service for ...
... The Arabidopsis 2 Oligo Microarray Kit (V2), 22K ... stages, and stress response. Each microarray contains content ... The Institute for Genomic Research (TIGR) and represents ... 5 standard 1 x 3? glass slides ...
... costs of poor quality running into ... organizations are under increasing pressure to ... production, the microscopic distribution of ingredients ... parameters such as dissolution, stability, bio-availability ...
Biology Products: